Navigation Links
Prime Hires Rachelle Wan as Vice President of Pharmaceutical Trade Relations
Date:4/24/2008

ST. PAUL, Minn., April 24 /PRNewswire/ -- Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that Rachelle Wan, RPh, has joined the organization as Vice President of Pharmacy Trade Relations.

As Vice President of Pharmacy Trade Relations, Wan will focus on developing and maintaining relationships with the pharmaceutical industry. She will lead Prime's efforts in the development of strategic pharmacy contracts and the performance of rebate and administrative fee agreements.

"Rachelle Wan is a great addition to Prime and brings exceptional experience developing and maintaining relationships," said Charles Roehrick, Chief Financial Officer at Prime. "Prime is an industry leader in providing innovative pharmacy solutions. We are excited to have Rachelle's leadership and expertise in this arena to help us create and manage strong and dependable relationships within the industry."

Wan, a Registered Pharmacist, earned a Bachelor of Science in Pharmacy from the University of Minnesota and a Masters Degree from the University of St. Thomas in St. Paul. She held several strategic contracting positions at PCS Health Systems/Caremark and was most recently a Corporate Account Manager at Amgen.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 10 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. North America Primed for Pet Insurance Market Expansion and Expecting $1.1 Billion by 2012
2. Human breast tumors microenvironment primes them for metastasis
3. VeriPrime Approves New Best Practices for Beef Production
4. VeriPrime Certified Safeguards Food Safety Label Unveiled
5. Food Policy Institute primer on food imports and regulations
6. Prime Healthcare Services Enters Into Network Wide Contract With Aetna Health Plans
7. Prime Therapeutics Introduces Efficiency Program to Help Employers Understand How to Most Effectively Spend Pharmacy Dollars
8. Prime Your Immune System During the Peak of Cold Season and Beyond
9. PrimeWest Health Chooses Healthations AboveHealth as Next Generation Provider Portal
10. Prime Therapeutics Becomes First PBM to Join the Center for Health Value Innovation
11. Health Capital Group Warns of Fallout to Hospitals From the Subprime Mortgage Crisis and Urges Hospitals to Immediately Reassess Existing Debt Structures and Capital Financing Plans

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... On Sunday, more than 900 runners and ... cross the finish line at the Rock ‘n’...m, raising over $3.2 million for the Crohn,s &...ning program, Team Challenge (www.ccteamchallenge)...ill go toward research, education, and support ini...
(Date:12/2/2009)...ATLANTA, Dec. 2 In response to ris...tary, FamilyLife, a non-profit ministry dedicated ... its Weekend to Remember® marriage conferen...n Atlanta from Dec. 11 - 13 at the Grand Hyatt Atl...nd to Remember is a marriage getaway aimed at str...
(Date:12/2/2009)... Ad in Today,s Washington Post Highlights Da...wire/ -- If the Catholic bishops have their way...s we take for granted may be under threat. The pr... the debate over healthcare reform has been widely...t warns of the likely impact if that pressure to ...
(Date:12/2/2009)... , KANSAS CITY, Mo., Dec. 2 ...h a comprehensive, practical view on proposed heal...,, (Logo: http://www.newscom.com/cgi-bin/prnh/...is good, bad, and ugly in the legislation, accordi...Lockton Benefit Group,s Compliance Services Divis...
(Date:12/2/2009)...yriad microbes in tobacco, but risk is unclear , ...New research provides evidence that the average ci... that cause respiratory disease. , But as one s...thors of the new study aren,t sure what, if any, h...nothing new: Microbes surround us every day of our...
Breaking Medicine News(10 mins):Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 4Health News:FamilyLife Supports Military Marriages in Atlanta 2Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:Lockton Outlines Implications of Proposed Health Reform Plans 2Health News:Smokers Inhaling Germs With Each Cigarette 2
...obesity stats, the American Heart Association (AHA...ucation programs// in the daily curriculum. ... of years, and in order for them to be as physical... nine practical steps to see that kids exercise mo...
...rchers says that getting married may benefit depre...rlier studies have documented marriage as being be...t this is the first study to look at the mental he...co-author Adrianne Frech, a doctoral student in so...
...as approved the new anti-smoking drug called Chant... on the body//. Research on the effects of this d...ers were able to completely quit smoking, which ha...fectively blocks the withdrawal symptoms. Manufact...
...t his life when some students pushed him from the .../ on the floor. Qamar Irfan, a Class 5 studen...Manihas village, died Thursday. Police said Q... the class as soon as school opened and sat on the...
...e plan for six new private finance initiative hosp... cutbacks// in their budgets. The announcement...nue the largest hospital building programme in the... Under the plans, , Bart’s and the London will lo...
...ch is needed to to fill in the gaps in HIV vaccine...itut Pasteur//, France, at the 16th International ...to Dr. Barré-Sinoussi there have been 85 HIV vacci...ussi said that recent advances in fundamental immu...
Other Medicine News:Health News:Proposal to Build Six new Hospitals Met with Rage 2
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 /PRNews...ncluding a late-breaking presentation on Tasigna&#...nic myeloid leukemia, demonstrate the strength of ...e care of patients. ,, The new data, at the 51...ting and Exposition, highlight the company,s curre...
(Date:12/1/2009)... , NEW YORK, Dec . 1 Re...h report is available in its catalogue: ,, Ins..., http://www.reportlinker.com/p0164247/Insulin-P...Insulin pumps, also called Continuous Subcutaneous...ver diabetes, when compared to other forms of trea...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Re...h report is available in its catalogue: ,, HPL...w ,, http://www.reportlinker.com/p0164366/HPL...l ,, Over the years, Liquid Chromatography has...s, pharmaceuticals, food and beverage, research an...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7Carondelet St Marys Medical Plaza II Opens In Tucson 55314 1Long term tamoxifen use increases risk of an aggressive hard to treat type of second breast cancer 55312 1Long term tamoxifen use increases risk of an aggressive hard to treat type of second breast cancer 55312 2UTs Valentin Dragoi gets 241 2 million grant for groundbreaking approach to brain research 9695 1UTs Valentin Dragoi gets 241 2 million grant for groundbreaking approach to brain research 9695 2UTs Valentin Dragoi gets 241 2 million grant for groundbreaking approach to brain research 9695 3
Narkomed GS
...in facilities where space is a premium Fabius Tiro...technologies with an ergonomic and compact design....raeger Infinity patient monitoring range allows yo...is a sound investment into the future. The open mo...
...eveloped using Datex-Ohmedas unique approach to an...uous collaboration with clinicians. It combines th...atex-Ohmeda monitoring technology into an affordab...out the world, ,The contemporary, compact design ...
... Absorbent Wound Dressing is a sterile, single use... dressing applications. The synthetic matrix abso... wound contours, and entraps slough and necrotic d... The strands of the matrix are bound together by ...
Medicine Products: